Tuesday, September 17, 2013

EMA approves biosimilar Somatropin from Biopartners Gmbh

The European Medicine agency has approved a biosimilar somatropin from Biopartners GMBH. Somatropin biopartner would be the  third biosimilar version of somatropin the European market. Other players selling somatropin inlcude Sandoz and Roche.  Sandoz sells under the brand Omnitrope, while Roche which is the innovator of somatropin sells it under the brand name NutropinAq.
Nutropin the innovator copy generated WW annual sale of approximately $350m in 2011.



Enter your email address:


Delivered by FeedBurner